(Q51333450)

English

Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose.

scientific article published in January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Ying Han

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

An-Lin Ma

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yun Xu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xiao-Dong Ding

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jian-Gao Fan

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

1 January 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Clinical Drug Investigation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Metformin in the treatment of patients with non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Bicyclol: a novel drug for treating chronic viral hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Nonalcoholic steatohepatitis and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Non-alcoholic fatty liver disease and the metabolic syndrome: an update

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Fatty liver: a novel component of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Carotid artery intima-media thickness in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Mechanism of protective action of bicyclol against CCl-induced liver injury in mice

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Protective effect of bicyclol on acute alcohol-induced liver injury in mice

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0136-3

21 January 2018

Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Editorial: Fatty liver disease: a growing public health problem worldwide

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Efficacy comparison between bicyclol and polyene phosphatidylcholine treatments for the patients with nonalcoholic fatty liver disease]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40261-013-0136-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

release_gtr5oykegjgvpevwjpaa2gru54

1 reference

https://api.fatcat.wiki/v0/release/gtr5oykegjgvpevwjpaa2gru54

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081374%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51333450&oldid=1837325340"